Skip to main content
OpenTrials
Completed

NCT Number: NCT00910013

Femoral Block With or Without Ropivacaine for Analgesia After Total Knee Replacement (TKR)

Total knee replacement is a painful procedure. Many solutions have been proposed to diminish the post-operative doses of narcotics, including nerve blocks.

The purpose of the study is to compare if the adjunction of intra-articular ropivacaine to a femoral block is more effective on narcotics consumption than the block alone after TKR.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

CHA-Pavillon Enfant-Jésus

Québec, Quebec, G1J1Z4, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary total knee replacement
  • Age > 18 years old
  • Accept the study

Exclusion criteria

  • Revision surgery
  • Use of anticoagulants drugs
  • Neurologic disorder
  • Unable to sign consent form

Treatment and study plan

Ropivacaine

Drug

0.5% intra-articular ropivacaïne (20cc)

Primary outcomes

  1. Narcotic consumption per 24 hours after surgery (mg/kg)

    Time frame: 48 hours

Secondary outcomes

  1. VAS score at 24 hours

    Time frame: 48 hours

Sponsors and collaborators

Lead sponsor

Hopital de l'Enfant-Jesus

Other

Registry information

Official study title

A Randomized Trial Comparing the Efficacy on Post-operative Analgesia of Intra-articular Ropivacaine Added to a Femoral Block After Total Knee Replacement

Acronym: TKR

Important dates

Study start
2006
Primary completion
2008
Study completion
2008
First posted
May 29, 2009
Registry last updated
Feb 28, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.